FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2496367306> ?p ?o ?g. }

• W2496367306 endingPage "1873" @default.
• W2496367306 startingPage "1867" @default.
• W2496367306 abstract "We carried out post-transplantation cyclophosphamide (PTCy)-based haploidentical peripheral blood stem cell transplantation in 51 patients with refractory/relapsed acute myeloid leukemia not in remission. The first 10 patients received nonmyeloablative conditioning followed by planned granulocyte colony-stimulating factor (G-CSF)–mobilized donor lymphocyte infusions (DLIs) on days 35, 60, and 90. No patient developed graft-versus-host disease (GVHD), but 90% had disease progression between 3 and 6 months. A subsequent 41 patients received myeloablative conditioning (MAC); the first 20 patients did not receive DLIs (MAC group) and the next 21 patients received G-CSF–mobilized DLIs (G-DLI) on days 21, 35, and 60 (MAC-DLI group). The incidence of disease progression and progression-free survival at 18 months were 66% and 25% in the MAC group compared with 21.4% and 61.9% in the MAC-DLI group (P = .01). Chronic GVHD but not acute GVHD was increased in the MAC-DLI group (41.2% versus 11%, P = .05). Natural killer cell alloreactive donor was associated with lower incidence of disease progression in the MAC but not in MAC-DLI group. The only factor favorably influencing disease progression and progression-free survival was administration of G-DLI after myeloablative conditioning. Our study shows that early administration of G-DLI is feasible after PTCy-based haploidentical hematopoietic stem cell transplantation for refractory/relapsed acute myeloid leukemia and might be associated with improved survival after MAC." @default.
• W2496367306 created "2016-08-23" @default.
• W2496367306 creator A5000856914 @default.
• W2496367306 creator A5010778598 @default.
• W2496367306 creator A5028360495 @default.
• W2496367306 creator A5042444282 @default.
• W2496367306 creator A5052927157 @default.
• W2496367306 creator A5053912575 @default.
• W2496367306 creator A5057113106 @default.
• W2496367306 creator A5077775706 @default.
• W2496367306 creator A5087793925 @default.
• W2496367306 date "2016-10-01" @default.
• W2496367306 modified "2023-10-11" @default.
• W2496367306 title "Improved Outcome of Refractory/Relapsed Acute Myeloid Leukemia after Post-Transplantation Cyclophosphamide-Based Haploidentical Transplantation with Myeloablative Conditioning and Early Prophylactic Granulocyte Colony-Stimulating Factor–Mobilized Donor Lymphocyte Infusions" @default.
• W2496367306 cites W1707184873 @default.
• W2496367306 cites W1873141201 @default.
• W2496367306 cites W1977794804 @default.
• W2496367306 cites W1978782366 @default.
• W2496367306 cites W1979309423 @default.
• W2496367306 cites W1982766090 @default.
• W2496367306 cites W1984898983 @default.
• W2496367306 cites W1999431876 @default.
• W2496367306 cites W2012583698 @default.
• W2496367306 cites W2029047332 @default.
• W2496367306 cites W2044467556 @default.
• W2496367306 cites W2046843493 @default.
• W2496367306 cites W2052266476 @default.
• W2496367306 cites W2055236259 @default.
• W2496367306 cites W2057781614 @default.
• W2496367306 cites W2066339284 @default.
• W2496367306 cites W2075049419 @default.
• W2496367306 cites W2075354097 @default.
• W2496367306 cites W2077173355 @default.
• W2496367306 cites W2116483603 @default.
• W2496367306 cites W2135003681 @default.
• W2496367306 cites W2137465585 @default.
• W2496367306 cites W2138232273 @default.
• W2496367306 cites W2143034151 @default.
• W2496367306 cites W2147773887 @default.
• W2496367306 cites W2166247867 @default.
• W2496367306 cites W2211748454 @default.
• W2496367306 cites W2215252198 @default.
• W2496367306 cites W2311567335 @default.
• W2496367306 cites W2317548431 @default.
• W2496367306 cites W2329050949 @default.
• W2496367306 cites W2379365975 @default.
• W2496367306 cites W2396634526 @default.
• W2496367306 doi "https://doi.org/10.1016/j.bbmt.2016.07.016" @default.
• W2496367306 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27470289" @default.
• W2496367306 hasPublicationYear "2016" @default.
• W2496367306 type Work @default.
• W2496367306 sameAs 2496367306 @default.
• W2496367306 citedByCount "59" @default.
• W2496367306 countsByYear W24963673062017 @default.
• W2496367306 countsByYear W24963673062018 @default.
• W2496367306 countsByYear W24963673062019 @default.
• W2496367306 countsByYear W24963673062020 @default.
• W2496367306 countsByYear W24963673062021 @default.
• W2496367306 countsByYear W24963673062022 @default.
• W2496367306 countsByYear W24963673062023 @default.
• W2496367306 crossrefType "journal-article" @default.
• W2496367306 hasAuthorship W2496367306A5000856914 @default.
• W2496367306 hasAuthorship W2496367306A5010778598 @default.
• W2496367306 hasAuthorship W2496367306A5028360495 @default.
• W2496367306 hasAuthorship W2496367306A5042444282 @default.
• W2496367306 hasAuthorship W2496367306A5052927157 @default.
• W2496367306 hasAuthorship W2496367306A5053912575 @default.
• W2496367306 hasAuthorship W2496367306A5057113106 @default.
• W2496367306 hasAuthorship W2496367306A5077775706 @default.
• W2496367306 hasAuthorship W2496367306A5087793925 @default.
• W2496367306 hasBestOaLocation W24963673061 @default.
• W2496367306 hasConcept C126322002 @default.
• W2496367306 hasConcept C141071460 @default.
• W2496367306 hasConcept C203014093 @default.
• W2496367306 hasConcept C2776694085 @default.
• W2496367306 hasConcept C2776755627 @default.
• W2496367306 hasConcept C2777408962 @default.
• W2496367306 hasConcept C2777767877 @default.
• W2496367306 hasConcept C2778461978 @default.
• W2496367306 hasConcept C2778729363 @default.
• W2496367306 hasConcept C2779282312 @default.
• W2496367306 hasConcept C2779695342 @default.
• W2496367306 hasConcept C2911091166 @default.
• W2496367306 hasConcept C71924100 @default.
• W2496367306 hasConcept C90924648 @default.
• W2496367306 hasConceptScore W2496367306C126322002 @default.
• W2496367306 hasConceptScore W2496367306C141071460 @default.
• W2496367306 hasConceptScore W2496367306C203014093 @default.
• W2496367306 hasConceptScore W2496367306C2776694085 @default.
• W2496367306 hasConceptScore W2496367306C2776755627 @default.
• W2496367306 hasConceptScore W2496367306C2777408962 @default.
• W2496367306 hasConceptScore W2496367306C2777767877 @default.
• W2496367306 hasConceptScore W2496367306C2778461978 @default.
• W2496367306 hasConceptScore W2496367306C2778729363 @default.
• W2496367306 hasConceptScore W2496367306C2779282312 @default.
• W2496367306 hasConceptScore W2496367306C2779695342 @default.
• W2496367306 hasConceptScore W2496367306C2911091166 @default.
• W2496367306 hasConceptScore W2496367306C71924100 @default.

• next